Przybek-Skrzypecka Joanna, Ryk-Adamska Małgorzata, Szewczuk Alina, Skrzypecki Janusz, Izdebska Justyna, Udziela Monika, Rypniewska Anna, Suh Leejee H, Szaflik Jacek P
Department of Ophthalmology, Medical University of Warsaw, Sierakowskiego 13, 01-756 Warsaw, Poland.
SPKSO Ophthalmic University Hospital Warsaw, 03-709 Warsaw, Poland.
J Clin Med. 2024 Dec 28;14(1):124. doi: 10.3390/jcm14010124.
To evaluate visual acuity improvement and identify contributing factors in patients with severe keratitis affecting both virgin and transplanted corneas, treated at a hospital. A retrospective analysis was conducted on 497 patients with unilateral corneal ulcers treated at a tertiary referral center between 2008 and 2023. Data included distance (BCVA) and near best-corrected visual acuity at initial presentation and at discharge, treatments before hospital admission, demographic details, risk factors, clinical signs and symptoms, ancillary test results, and management strategies. Patients were categorized into two groups: Group A (naïve corneal ulcers, 379 patients) and Group B (post-keratoplasty infectious keratitis, 118 patients). Additional analysis focused on patients with presenting visual acuity of at least 1.0 logMAR (≤5/50 Snellen charts = legal blindness) to predict final visual outcomes. The median BCVA at presentation for the entire cohort was 1.9 logMAR, advancing to 1.5 logMAR at discharge ( < 0.001). At least one line improvement in BCVA was observed in 47% of patients (52% of naïve cornea and 33% of transplanted cornea patients). Significantly worse results were observed in Group B were observed for BCVA at presentation, BCVA improvement, and distance and near vision improvement. Among patients with legal blindness at presentation, vision status improved for 52/379 (14%) in Group A and 6/118 (5%) in Group B during hospital admission ( < 0.001), while 67% of the cohort was discharged with VA equal or worse than 5/50. The average hospital stay was 9 days. Near visual acuity got better in 23% of patients (27% in Group A vs. 9% in Group B). A multivariate regression model showed that older age and worse distance BCVA on admission were independent negative predictors of improvement ( < 0.001, < 0.001, respectively) while midperiphery ulcers were associated with better visual outcomes. Hospital admission leads to BCVA improvement in 47% of the patients with severe corneal ulcer, though the prognosis is significantly worse for those with post-keratoplasty microbial keratitis. At discharge, 67% of patients remained at the legal blindness level. Older age and lower BCVA at first presentation are associated with worse prognosis, while ulcers located in the corneal midperiphery are linked to better visual outcomes.
为评估在一家医院接受治疗的、双眼角膜均受严重角膜炎影响(包括未移植角膜和移植角膜)患者的视力改善情况并确定相关影响因素,对2008年至2023年在一家三级转诊中心接受治疗的497名单侧角膜溃疡患者进行了回顾性分析。数据包括初诊时和出院时的远视力(最佳矫正视力,BCVA)及近视力、入院前的治疗情况、人口统计学细节、危险因素、临床体征和症状、辅助检查结果以及治疗策略。患者被分为两组:A组(单纯角膜溃疡,379例患者)和B组(角膜移植术后感染性角膜炎,118例患者)。进一步分析聚焦于初诊视力至少为1.0 logMAR(≤5/50 Snellen视力表=法定盲)的患者,以预测最终视力结果。整个队列初诊时的BCVA中位数为1.9 logMAR,出院时提高到1.5 logMAR(P<0.001)。47%的患者BCVA至少提高了一行(单纯角膜患者中为52%,移植角膜患者中为33%)。B组在初诊时的BCVA、BCVA改善情况以及远视力和近视力改善方面的结果明显更差。在初诊时为法定盲的患者中,住院期间A组52/379(14%)和B组6/118(5%)的视力状况有所改善(P<0.001),而67%的队列患者出院时视力等于或低于5/50。平均住院时间为9天。23%的患者近视力有所改善(A组为27%,B组为9%)。多因素回归模型显示,年龄较大和入院时远视力BCVA较差是视力改善的独立负性预测因素(分别为P<0.001,P<0.001),而角膜中周边溃疡与更好的视力结果相关。住院治疗使47%的严重角膜溃疡患者BCVA得到改善,不过角膜移植术后微生物性角膜炎患者的预后明显更差。出院时,67%的患者仍处于法定盲水平。年龄较大和初诊时BCVA较低与较差的预后相关,而位于角膜中周边的溃疡与更好的视力结果相关。